Xianlong Fang

Title: Xianlong Fang: Innovator in Oncolytic Virus Research

Introduction

Xianlong Fang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic viruses for cancer treatment. With a total of 2 patents, Fang's work is paving the way for innovative therapeutic approaches.

Latest Patents

Fang's latest patents include groundbreaking research on oncolytic viruses. One of his notable inventions is an oncolytic virus expressing interferon. This invention provides an oncolytic adenovirus that comprises a fusion protein expressing interferon, which is capable of effectively suppressing tumors both in vitro and in vivo. Another significant patent is for an oncolytic virus expressing a PD-1 binding protein. This oncolytic adenovirus includes a fusion protein that expresses a PD-1 single-chain antibody, designed to enhance the immune response against tumors.

Career Highlights

Xianlong Fang is associated with Shanghai Yuansong Biotechnology Co. Ltd., where he continues to advance his research in oncolytic virus technology. His work is characterized by a commitment to developing innovative solutions for cancer treatment, showcasing his expertise in the field.

Collaborations

Fang collaborates with notable colleagues, including Kangjian Zhang and Jinfa Gu. Their combined efforts contribute to the advancement of research in biotechnology and cancer therapies.

Conclusion

Xianlong Fang's innovative work in oncolytic virus research exemplifies the potential of biotechnology in transforming cancer treatment. His patents reflect a dedication to improving therapeutic strategies, making a significant impact in the field.